Spyros Papapetropoulos

Business address
C/O Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, Emeryville, CA, 94608
Top holdings (ownership)
VIGL, NEUP, and LPCN
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Spyros Papapetropoulos has filed 20 SEC EDGAR filings since 24 Nov 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 02 Sep 2025 27 Aug 2025 001-41157
4 Open Document Open Filing 05 Jun 2025 04 Jun 2025 001-36357
4/A Open Document Open Filing 19 May 2025 16 Apr 2025 001-41157
4 Open Document Open Filing OWNERSHIP DOCUMENT 18 Apr 2025 16 Apr 2025 001-41157
3 Open Document Open Filing 08 Jul 2024 01 Jul 2024 001-41157
4 Open Document Open Filing 07 Jun 2024 05 Jun 2024 001-36357
4 Open Document Open Filing 12 May 2023 10 May 2023 001-36357
4 Open Document Open Filing 28 Nov 2022 22 Nov 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION 22 Nov 2022 18 Nov 2022 001-41200
4 Open Document Open Filing 10 Jun 2022 08 Jun 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION 04 May 2022 03 May 2022 001-41200
4 Open Document Open Filing 12 Apr 2022 11 Apr 2022 001-36357
3 Open Document Open Filing 12 Apr 2022 11 Apr 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION 03 Mar 2022 01 Mar 2022 001-41200
3 Open Document Open Filing FORM 3 SUBMISSION 06 Jan 2022 06 Jan 2022 001-41200
4 Open Document Open Filing FORM 4 24 Nov 2021 24 Nov 2021 001-36399
4 Open Document Open Filing FORM 4 04 Jun 2021 02 Jun 2021 001-36399
4 Open Document Open Filing FORM 4 SUBMISSION 15 Mar 2021 11 Mar 2021 001-36399
4 Open Document Open Filing FORM 4 SUBMISSION 24 Nov 2020 22 Nov 2020 001-36399
3 Open Document Open Filing FORM 3 SUBMISSION 24 Nov 2020 22 Nov 2020 001-36399